Cost

ALL CODES   A CODE   B CODE   C CODE   CPT CODE   J CODE   NOC CODE   P CODE   Q CODE   S CODE  COST

OPFOLDA – Cost

OPFOLDA, HCPCS J1202, became effective on April 1, 2024, and has three NDCs mapped to J Code: J1202. There has been no change in pricing since inception. AWP has remained slightly higher than WAC.

Read More »

RYKINDO – Cost

RYKINDO, became effective on April 1, 2024, and is associated with HCPCS J2801. RYKINDO has six NDCs mapped to J Code: 2801 with no discrepancies found within these alignments. Pricing between WAC and AWP have remained relatively close with no

Read More »

Veopoz – Cost

Veopoz, manufactured by REGENERON PHARMACEUTICALS, became effective on April 1, 2024 and is associated with HCPCS J9376. Veopoz has two NDCs aligned to J Code: J9376. Since inception, pricing has remained level with AWP being 20% higher than WAC.

Read More »

CEFAZOLIN – Cost

CEFAZOLIN’s HCPCS J0688, became effective on January 1, 2024. CEFAZOLIN has two NDCs aligned to J Code: J0688 with no errors found. ASP has held just over 30% below WAC.

Read More »

REZZAYO – Cost

REZZAYO, a product of MELINTA THERAPEUTICS, LLC, became effective on October 1, 2023 and is aligned to J Code: J0349. From the end of 2023 through the first quarter of 2024, prices have remained steadt.

Read More »

SINCALIDE – Cost

SINCALIDE, became effective on July 1, 2023, and is associated with HCPCS J2806. There are two NDCs aligned to J Code: J2806 with one possible error found within these mappings. Prices have remained level through the beginning of 2024.

Read More »

BYFAVO – Cost

BYFAVO’s HCPCS became effective on July 1, 2023. There are two NDCs aligned to J Code: J2249 with one possible error or discrepancy found. AWP and WAC have remained level at their introductory prices through the first quarter of 2024.

Read More »

FUROSCIX – Cost

FUROSCIX, manufactured by SCPHARMACEUTICALS, became effective on July 1, 2023, and is aligned to J Code: J1941. Through the end of 2023, both WAC and AWP remained unchanged. At the beginning of 2024, both experienced a slight increase of roughly

Read More »

ALFENTA – Cost

ALFENTA, became effective on July 1, 2023, and is associated with HCPCS J0216. ALFENTA has two NDCs aligned to J Code: J0216 with potential errors found within both of these mappings.

Read More »

SEZABY – Cost

SEZABY, a product of SUN PHARMACEUTICALS, became effective on July 1, 2023, and is aligned to HCPCS J2561. There have been no significant price changes through 2024. Both WAC and AWP remain relatively close.

Read More »